Brookfield Asset Management - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,060,114
-59.2%
123,193
-75.3%
0.01%
-58.6%
Q1 2023$7,494,297
+148.0%
498,291
+95.1%
0.03%
+163.6%
Q4 2022$3,021,962
+71.4%
255,449
-14.2%
0.01%
+83.3%
Q3 2022$1,763,000
+79.9%
297,843
+29.1%
0.01%
+50.0%
Q2 2022$980,000
-43.9%
230,690
+25.5%
0.00%
-33.3%
Q1 2022$1,748,000
+34.7%
183,793
+169.1%
0.01%
+20.0%
Q4 2021$1,298,000
+42.6%
68,309
+150.0%
0.01%
+25.0%
Q3 2021$910,000
+27.1%
27,329
+48.1%
0.00%
+33.3%
Q2 2021$716,00018,4490.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders